Aker BioMarine ASA (OSE: AKBM.OL) is a leading biotechnology company specializing in sustainable krill harvesting and marine ingredients. With a fully integrated value chain from harvesting to end-product, the company is well-positioned to benefit from the growing demand for sustainable protein and omega-3 supplements.
Our thesis centers on the company’s unique position in the food supply chain, its strong balance sheet, and multiple catalysts expected over the next 12 months. The company has been investing in expanding its product portfolio and improving operational efficiency, which should drive margin expansion and earnings growth.
Key catalysts include the full-year impact of cost-saving initiatives, potential new product launches, and continued growth in the krill oil market. Risks include krill quota fluctuations and currency exposure.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research before making investment decisions.